IP Verse

Lederer & Keller Patentanwalte Partnerschaft Mbb patent opposition analysis

The comprehensive analysis of Lederer & Keller Patentanwalte Partnerschaft Mbb opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Lederer & Keller Patentanwalte Partnerschaft Mbb

Stay updated with the latest patent oppositions filed by Lederer & Keller Patentanwalte Partnerschaft Mbb

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3574914
Corticosteroid CompositionsVIROPHARMA BIOLOGICSSep 1, 2022DR FALK PHARMA
EP3437645
Film-Coated Tablet Having High Chemical Stability Of Active IngredientINTERCEPT PHARMACEUTICALSJun 21, 2022SANDOZ
EP2585075
Methods Of Treatment For Esophageal InflammationMERITAGE PHARMAMay 4, 2022DR FALK PHARMA
EP2863895
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 11, 2022TEVA PHARMACEUTICALS
EP3094681
Propylene-Based Impact CopolymersEXXONMOBIL CHEMICAL PATENTSOct 19, 2021LUMMUS NOVOLEN TECHNOLOGY
EP2545939
Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICALSep 14, 2021TEVA PHARMACEUTICALS
EP3337467
Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer TreatmentIPSEN BIOPHARMSep 9, 2021SANDOZ
EP2478907
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJul 6, 2021TEVA PHARMACEUTICALS
EP2970389
Pharmaceutical CompositionsRHYTHM PHARMACEUTICALSMay 18, 2021SANDOZ
EP2726517
Improved Process For Gas-Phase Polymerization Having High Polymer Bed Bulk DensityWR GRACE & CONNMar 3, 2021LUMMUS NOVOLEN TECHNOLOGY

Top clients of Lederer & Keller Patentanwalte Partnerschaft Mbb

Top companies who are the clients of Lederer & Keller Patentanwalte Partnerschaft Mbb

CompanyTotal
TEVA PHARMACEUTICALS10
DR FALK PHARMA8
LEDERER & KELLER6
SANDOZ4
HEXAL4
DSM NUTRITIONAL PRODUCTS3
LUMMUS NOVOLEN TECHNOLOGY3
LUYE PHARMA SWITZERLAND1
PENTAFARMA SOCIEDADE TECNICO MEDICINAL1
STADA ARZNEIMITTEL1